Cargando…

Multifractal foundations of biomarker discovery for heart disease and stroke

Any reliable biomarker has to be specific, generalizable, and reproducible across individuals and contexts. The exact values of such a biomarker must represent similar health states in different individuals and at different times within the same individual to result in the minimum possible false-pos...

Descripción completa

Detalles Bibliográficos
Autores principales: Mangalam, Madhur, Sadri, Arash, Hayano, Junichiro, Watanabe, Eiichi, Kiyono, Ken, Kelty-Stephen, Damian G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600152/
https://www.ncbi.nlm.nih.gov/pubmed/37880302
http://dx.doi.org/10.1038/s41598-023-45184-2
_version_ 1785125926688784384
author Mangalam, Madhur
Sadri, Arash
Hayano, Junichiro
Watanabe, Eiichi
Kiyono, Ken
Kelty-Stephen, Damian G.
author_facet Mangalam, Madhur
Sadri, Arash
Hayano, Junichiro
Watanabe, Eiichi
Kiyono, Ken
Kelty-Stephen, Damian G.
author_sort Mangalam, Madhur
collection PubMed
description Any reliable biomarker has to be specific, generalizable, and reproducible across individuals and contexts. The exact values of such a biomarker must represent similar health states in different individuals and at different times within the same individual to result in the minimum possible false-positive and false-negative rates. The application of standard cut-off points and risk scores across populations hinges upon the assumption of such generalizability. Such generalizability, in turn, hinges upon this condition that the phenomenon investigated by current statistical methods is ergodic, i.e., its statistical measures converge over individuals and time within the finite limit of observations. However, emerging evidence indicates that biological processes abound with nonergodicity, threatening this generalizability. Here, we present a solution for how to make generalizable inferences by deriving ergodic descriptions of nonergodic phenomena. For this aim, we proposed capturing the origin of ergodicity-breaking in many biological processes: cascade dynamics. To assess our hypotheses, we embraced the challenge of identifying reliable biomarkers for heart disease and stroke, which, despite being the leading cause of death worldwide and decades of research, lacks reliable biomarkers and risk stratification tools. We showed that raw R-R interval data and its common descriptors based on mean and variance are nonergodic and non-specific. On the other hand, the cascade-dynamical descriptors, the Hurst exponent encoding linear temporal correlations, and multifractal nonlinearity encoding nonlinear interactions across scales described the nonergodic heart rate variability more ergodically and were specific. This study inaugurates applying the critical concept of ergodicity in discovering and applying digital biomarkers of health and disease.
format Online
Article
Text
id pubmed-10600152
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-106001522023-10-27 Multifractal foundations of biomarker discovery for heart disease and stroke Mangalam, Madhur Sadri, Arash Hayano, Junichiro Watanabe, Eiichi Kiyono, Ken Kelty-Stephen, Damian G. Sci Rep Article Any reliable biomarker has to be specific, generalizable, and reproducible across individuals and contexts. The exact values of such a biomarker must represent similar health states in different individuals and at different times within the same individual to result in the minimum possible false-positive and false-negative rates. The application of standard cut-off points and risk scores across populations hinges upon the assumption of such generalizability. Such generalizability, in turn, hinges upon this condition that the phenomenon investigated by current statistical methods is ergodic, i.e., its statistical measures converge over individuals and time within the finite limit of observations. However, emerging evidence indicates that biological processes abound with nonergodicity, threatening this generalizability. Here, we present a solution for how to make generalizable inferences by deriving ergodic descriptions of nonergodic phenomena. For this aim, we proposed capturing the origin of ergodicity-breaking in many biological processes: cascade dynamics. To assess our hypotheses, we embraced the challenge of identifying reliable biomarkers for heart disease and stroke, which, despite being the leading cause of death worldwide and decades of research, lacks reliable biomarkers and risk stratification tools. We showed that raw R-R interval data and its common descriptors based on mean and variance are nonergodic and non-specific. On the other hand, the cascade-dynamical descriptors, the Hurst exponent encoding linear temporal correlations, and multifractal nonlinearity encoding nonlinear interactions across scales described the nonergodic heart rate variability more ergodically and were specific. This study inaugurates applying the critical concept of ergodicity in discovering and applying digital biomarkers of health and disease. Nature Publishing Group UK 2023-10-25 /pmc/articles/PMC10600152/ /pubmed/37880302 http://dx.doi.org/10.1038/s41598-023-45184-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Mangalam, Madhur
Sadri, Arash
Hayano, Junichiro
Watanabe, Eiichi
Kiyono, Ken
Kelty-Stephen, Damian G.
Multifractal foundations of biomarker discovery for heart disease and stroke
title Multifractal foundations of biomarker discovery for heart disease and stroke
title_full Multifractal foundations of biomarker discovery for heart disease and stroke
title_fullStr Multifractal foundations of biomarker discovery for heart disease and stroke
title_full_unstemmed Multifractal foundations of biomarker discovery for heart disease and stroke
title_short Multifractal foundations of biomarker discovery for heart disease and stroke
title_sort multifractal foundations of biomarker discovery for heart disease and stroke
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600152/
https://www.ncbi.nlm.nih.gov/pubmed/37880302
http://dx.doi.org/10.1038/s41598-023-45184-2
work_keys_str_mv AT mangalammadhur multifractalfoundationsofbiomarkerdiscoveryforheartdiseaseandstroke
AT sadriarash multifractalfoundationsofbiomarkerdiscoveryforheartdiseaseandstroke
AT hayanojunichiro multifractalfoundationsofbiomarkerdiscoveryforheartdiseaseandstroke
AT watanabeeiichi multifractalfoundationsofbiomarkerdiscoveryforheartdiseaseandstroke
AT kiyonoken multifractalfoundationsofbiomarkerdiscoveryforheartdiseaseandstroke
AT keltystephendamiang multifractalfoundationsofbiomarkerdiscoveryforheartdiseaseandstroke